自1997年以来,医药类企业并购重组情况一直比较活跃,所占比例在全部并购中的3％以上,其原因何在?我们的观点是:行业发展的差异性,以及行业整合的迫切性导致了医药行业间的并购重组有加速的趋势,而这种趋势从2000年开始到现在,医药类并购与全部并购的比例从5.83％一直增长到17.65％。 Since 1997, the merger and reorganization of pharmaceutical companies has been relatively active, accounting for more than 3% of all mergers and acquisitions, the reason why? Our point is: the development of the industry differences, as well as the urgency of industry consolidation led to The merger and reorganization between the pharmaceutical industry has accelerated the trend, and this trend from 2000 until now, the proportion of mergers and acquisitions and mergers and acquisitions all the way from 5.83% to 17.65%.